Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma.

In conclusion, mutations affecting genes involved in different pathways (pseudohypoxic and receptor tyrosine kinase signalling) co-occurring in the same patient could provide a selective advantage for the development of PPGL, and explain the variable expressivity and incomplete penetrance observed in some patients.